Radiological Contrast Agents and Kidney Disease: Understanding the Risks

For over half a century, it has been well-documented that radiological contrast agents can cause nephropathy, particularly in patients with pre-existing renal insufficiency. This has led to concerns about the use of MRI investigations in patients with renal disease, as gadolinium-based contrast agents have been linked to nephrogenic systemic fibrosis.

The complex relationship between contrast agents and the kidney is multifaceted. Not only can contrast agents cause kidney damage, but they can also be used as a diagnostic tool to identify kidney-related issues. In this book, a team of renowned experts delve into the various aspects of this relationship, aiming to provide a rational basis for the use of contrast agents.

The Importance of Understanding Contrast Agent Risks

In patients with renal disease, the risks associated with contrast agents can be severe. Nephrogenic systemic fibrosis, a condition caused by gadolinium-based contrast agents, can have serious consequences. It is essential that medical professionals understand the risks and benefits of using contrast agents in these patients to ensure safe and effective diagnoses.

This comprehensive book provides valuable insights into the relationship between contrast agents and kidney disease, offering practitioners a thorough understanding of the risks and benefits associated with their use.

Book Details:

• Authors: Michael Uder, Marc Heinrich
• Publisher: UNI-MED Verlag AG
• Edition: 1st edition
• Publication Date: January 24, 2014
• Language: Chinese